According to a new report, published by KBV research, The Global Veterinary Endocrinology Market size is expected to reach $482.2 billion by 2031, rising at a market growth of 6.6% CAGR during the forecast period.
The Others segment is anticipating a CAGR of 7.2% during (2024 - 2031). Some animals may have difficulty tolerating oral medications due to gastrointestinal issues, taste aversion, or difficulty swallowing pills. Alternative routes of administration, such as injectable formulations or transdermal patches, provide viable options for delivering medications to animals who cannot effectively receive treatment orally. Different routes of administration offer flexibility in treatment options, allowing veterinarians to tailor therapy to each animal's needs.
The Dogs segment is leading the Global Veterinary Endocrinology Market by Animal Type in 2023; thereby, achieving a market value of $280.5 million by 2031. Certain endocrine disorders, such as diabetes mellitus, hypothyroidism, and hyperadrenocorticism (Cushing’s disease), are more commonly diagnosed in dogs compared to other species. These conditions are prevalent, especially in middle-aged to older dogs, driving the demand for specialized endocrinology services. Dogs are among the most popular pets globally, with many pet owners and a significant household presence.
The Others segment is registering a CAGR of 7% during (2024 - 2031). There is growing awareness and improved diagnostic capabilities for a wide range of endocrine disorders in companion animals. Veterinarians are better equipped to recognize and diagnose conditions such as adrenal disorders, reproductive hormone imbalances, calcium metabolism disorders, and growth hormone abnormalities.
Full Report: https://www.kbvresearch.com/veterinary-endocrinology-market/
The North America region dominated the Global Veterinary Endocrinology Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $181.3 million by 2031. The Europe region is experiencing a CAGR of 6.4% during (2024 - 2031). Additionally, The Asia Pacific region would showcase a CAGR of 7.2% during (2024 - 2031).
By Route of Administration
By Animal Type
By Application
Unique Offerings 
